2026-2032 年中药市场（依适应症/治疗目的、剂型、来源、通路和地区划分）

中草药市场评估－2026-2032年

消费者意识的提高和对推广传统药物的投资增加正在推动草药的采用。因此，对基于阿育吠陀和尤纳尼教义的天然配方药物的需求正在上升，预计到 2024 年市场规模将超过 1,910.6 亿美元，到 2032 年将达到约 6,523 亿美元的估值。

除此之外，人们越来越意识到对抗疗法药物的潜在副作用和草药的益处，这也刺激了草药的采用。包括药品和补充剂在内的各个行业对草药的采用越来越多，使得市场在 2026 年至 2032 年期间的复合年增长率达到 18.30%。

中草药市场定义/概述

草药是从植物的根、茎、叶、花、种子等中提取的，用于促进健康和治疗疾病。常见的草药包括银杏、人参、生姜、姜黄和洋甘菊。几个世纪以来，当地人一直使用这些植物来配製药物来治疗人类和动物的疾病。

草药的用途和应用范围十分广泛，健康状况和健康促进目标也多种多样。草药疗法通常用于缓解流感、感冒、消化器官系统、头痛和肌肉酸痛等急性疾病的相关症状。它也用于治疗关节炎、过敏、心血管疾病和精神疾病等慢性疾病。此外，医疗保健支持免疫功能、压力管理、排毒和整体活力，在预防保健中发挥重要作用。草药製剂可以口服、局部或吸入的方式给药，这取决于所需的治疗效果和所用草药的特性。临床研究证明各种草药具有抗癌活性。本节根据这些药物对特定癌症类型的抑製作用对其临床使用进行分类。

银杏是一种传统药草，已被证明可以治疗循环系统疾病和增强记忆力，特别是在治疗痴呆失智症和间歇性跛行方面。卡瓦胡椒是一种改善情绪的草药，可能有助于治疗焦虑、失眠和神经病变。然而，有人担心卡瓦酒可能会造成肝臟病变。美国有超过 200 万名男性使用锯棕榈来治疗良性摄护腺增生 (BPH)。圣约翰草因其抗忧郁症特性而闻名。

新兴国家对天然药物日益增长的需求将如何推动草药市场的成长？

在新兴国家，草药是治疗轻微疾病的必需品，常常可以取代训练有素的医生和药剂师。这些药物可生用或晒干后製成茶、胶囊、锭剂、药膏和糊剂，用于内部治疗和治疗伤口。由于新兴经济体的监管很少，草药在这些国家被用于治疗各种疾病，预计未来几年该行业将会蓬勃发展。

草本产品电子商务销售额的成长很大程度上得益于网路购买体验的改善、有针对性的行销和线上教育。亚马逊等线上经销商已经开发了一系列草药产品，并根据具体情况和要求提供客製化清单的即时聊天选项和健康工具。这一趋势归因于网路购物体验的改善，从而推动了市场成长。

在新冠疫情期间，封锁和维持社交距离措施导致消费者对草药的需求激增。人们转向天然和有机产品（包括阿育吠陀补充剂和草药），以及对植物药在控制压力和焦虑水平方面的有效性的认识不断提高，促进了市场的增长。

政府对医疗保健互通性的投资不断增加，刺激了医疗保健产品和服务的采用。这些资金旨在改善患者的治疗效果、促进无缝资料交换并刺激医疗保健 IT 领域的创新。医疗保健支出的增加和基础设施的进步正在支持包括草药在内的医疗服务的扩展。这将促进草药融入主流医疗保健，并满足消费者对自然和替代疗法的需求。

草本指南缺乏统一性是否会抑制市场成长？

由于各国法律规范不同，草药市场面临重大限制。草药产品的进口、製造和标籤指南缺乏统一，使供应商和製造商的市场进入和合规变得复杂。这种分散的监管格局不仅增加了营运成本，而且由于企业需要应对不同的要求和标准，也阻碍了市场扩张。

对草药的安全性、功效和品质的担忧是另一个障碍。草药成分的科学检验和标准化测试通讯协定有限，常常会给消费者和医疗保健从业者带来不确定性。如果没有强有力的实证研究和监管监督，建立草药产品的信任和接受度将会很困难，从而阻碍其更广泛的采用和市场成长。

此外，儘管人们对自然疗法的兴趣日益浓厚，但由于缺乏转诊系统、资讯系统不完善以及医疗政策不协调等问题，草药融入主流医疗保健体系的速度一直很慢。

草本市场的成长受到原材料短缺、出口原材料成本上升以及合成成分和益生菌等强劲竞争对手的产品替代的阻碍。此外，伪草药产品的供应也是一个重大挑战。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章 中药材市场类型

• 锭剂和胶囊
• 粉末
• 胶囊和锭剂
• 糖浆
• 萃取物

第五章 草药市场（依来源）

• 叶子
• 根和树皮
• 全株及果实

第六章：中药材市场通路

• 医院
• 零售药局
• 电子商务

第七章. 依适应症/治疗用途分類的中药市场

• 消化器官系统健康
• 免疫支持
• 呼吸健康
• 心血管健康
• 关节和肌肉骨骼健康
• 压力管理/心理健康

第八章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第九章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第十章 竞争格局

• 主要企业
• 市场占有率分析

第十一章 公司简介

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Novartis International AG
• Bayer AG
• Pfizer Inc.
• GlaxoSmithKline plc.
• Sanofi SA
• Merck & Co., Inc.
• Eli Lilly and Company
• Johnson & Johnson
• Nestle SA
• Herbalife International of America, Inc.
• Amway Corporation
• Nature's Sunshine Products, Inc.
• Dabur India Ltd.
• Himalaya Global Holdings Ltd.

第十二章 市场展望市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十三章 附录

• 简称列表
• 来源和参考文献

Herbal Medicine Market Valuation - 2026-2032

The rise in consumer awareness and increased investments in promoting traditional medicine are propelling the adoption of herbal medicine. Thus, the rising demand for naturally prepared medicines based on Ayurvedic and Unani teachings has surged which is driving the market size surpass USD 191.06 Billion valued in 2024 to reach a valuation of around USD 652.3 Billion by 2032.

In addition to this, the increasing awareness of the potential negative impacts of allopathic medicines and the advantages of herbal medicinal products are spurring up the adoption of Herbal Medicine. The increasing adoption of herbal medicinal preparations has surged in various industries, including pharmaceuticals and supplements is enabling the market grow at a CAGR of 18.30% from 2026 to 2032.

Herbal Medicine Market: Definition/ Overview

Herbal medicines, derived from plants' roots, stems, leaves, flowers, or seeds, are used to improve health and treat illnesses. Popular herbs include gingko, ginseng, ginger, turmeric, and chamomile. Local communities have used these plants for centuries to prepare medicines for human and animal diseases.

The uses and applications of herbal medicine are extensive, spanning a wide range of health conditions and wellness goals. Herbal remedies are commonly used to alleviate symptoms associated with acute ailments such as flu, colds, digestive upset, headaches, and muscle pain. They are also employed for chronic conditions like arthritis, allergies, cardiovascular disease, and mental health disorders. Additionally, Herbal Medicine plays a crucial role in preventive healthcare, supporting immune function, stress management, detoxification, and overall vitality. Herbal preparations can be administered orally, topically, or through inhalation, depending on the desired therapeutic outcome and the specific properties of the herbs used. Clinical studies show a spectrum of anticancer activities from various herbal medicines. This section categorizes the clinical use of these medicines based on their suppressive effect on specific cancer types.

Ginkgo, a traditional medicine herb, has been shown to treat circulatory disorders and enhance memory, particularly in treating dementia and intermittent claudication. Kava kava, a mood-enhancing herb, may help treat anxiety, insomnia, and nervous disorders. However, there is concern that kava may cause liver damage. Saw palmetto, used by over 2 million men in the US, is used for treating benign prostatic hyperplasia (BPH). St. John's wort is known for its antidepressant effects.

How will Growing Demand for Natural Medicines in Developing Countries Drive the Growth of the Herbal Medicine Market?

Herbal medicines are crucial in developing countries for treating minor ailments, as they are often used in place of trained doctors or pharmacists. These medicines are unprocessed, dried, and used in teas, capsules, pills, salves, and poultices for internal healing and external injuries. Due to minimal regulations in developing economies, the industry is expected to grow rapidly in the coming years, as herbal medicines are used for various ailments in these countries.

The rise in herbal medicinal product sales in e-commerce is largely due to improved online purchase experiences, targeted marketing, and online education. Online distributors like Amazon have developed portfolios for herbal products, offering live chat options and wellness tools for customized lists based on specific conditions and requirements. This trend is attributed to improved online shopping experiences, this is bolstering the growth of the market

During the COVID-19 pandemic, consumer demand for herbal medicines surged due to lockdowns and social distancing measures. This shift towards natural and organic products, including Ayurveda supplements and herbal medicines, and increased awareness of botanicals' benefits in managing stress and anxiety levels contributed to market growth.

Increasing government investments in healthcare interoperability are driving the adoption of healthcare products and services. These funds aim to improve patient care outcomes, facilitate seamless data exchange, and stimulate innovation in healthcare IT. Increased healthcare expenditure and infrastructure advancements support the expansion of care delivery services, including herbal medicines. This promotes the integration of herbal medicinal products into mainstream healthcare practices, meeting consumer demand for natural and alternative treatments.

Will Lack of Uniformity in Guidelines of Herbal Medicine Restrain Its Market Growth?

The herbal medicine market faces significant constraints due to varying regulatory frameworks across different countries. Lack of uniformity in guidelines for importing, manufacturing, and labeling herbal products complicates market access and compliance for suppliers and manufacturers. This fragmented regulatory landscape not only increases operational costs but also impedes market expansion as companies navigate diverse requirements and standards.

Concerns regarding the safety, efficacy, and quality of herbal medicines pose another restraint. Limited scientific validation and standardized testing protocols for herbal ingredients often lead to uncertainty among consumers and healthcare practitioners. Without robust evidence-based research and regulatory oversight, establishing trust and acceptance in herbal products becomes challenging, hindering broader adoption and market growth.

Also, despite increasing interest in natural therapies, the integration of herbal medicines into mainstream healthcare systems is slow due to issues like lack of referral mechanisms, inadequate information systems, and uncoordinated healthcare policies.

The growth of the herbal medicine market is hindered by a shortage of raw materials and increased costs of exported ingredients, as well as product substitution, with synthetic ingredients and probiotics being strong competitors. The availability of pseudo-herbal products also poses a significant challenge.

Category-Wise Acumens

Which Factors Contributing Tablets & Capsules Segment Dominance in Herbal Medicine Market?

The tablets & capsules segment dominates the herbal medicine market due to the availability of various herbal medicines in capsules and tablets. With an increasing number of prescriptions mentioning herbal products, this segment is expected to remain dominant in the pharmaceutical industry during the forecast period.

Tablets and capsules allow for precise dosing of herbal extracts and active ingredients, ensuring consistency in therapeutic effects. This standardized format appeals to both consumers and healthcare providers seeking reliable and predictable outcomes. They have longer shelf life compared to liquid formulations, enhancing product stability and reducing wastage, benefiting manufacturers and retailers in inventory management and product availability.

Many consumers perceive tablets and capsules as more professional and medically acceptable forms of herbal medicine. This perception contributes to their popularity and widespread acceptance in the market.

Advancements in formulation technologies have enhanced the effectiveness, stability, and bioavailability of herbal ingredients in tablet and capsule formats, enhancing nutrient absorption and enhancing the delivery of herbal compounds, thus increasing their acceptance among health-conscious individuals.

Which Factors Enhance the Use of Leaves-Based Herbal Medicine?

Leaves segment is currently dominating in Herbal Medicine Market. The therapeutic properties of leaves, including their antioxidant, anti-inflammatory, and detoxifying effects, have fueled their increasing use in herbal remedies. Rich in bioactive compounds like polyphenols, flavonoids, and essential oils, leaves appeal to health-conscious consumers seeking natural alternatives.

The versatility of leaves allows for their incorporation into various herbal formulations, such as teas, extracts, tinctures, and topical preparations, addressing a wide range of health needs. This adaptability enhances their presence and dominance in the herbal medicine market.

Leaves have been used in traditional medicine systems for centuries, establishing trust and knowledge among consumers. Cultural practices and historical use continue to popularize leaves-based herbal remedies in modern healthcare. They are versatile and easy to prepare, making them suitable for consumption in teas, extracts, and dried formulations. Their mild flavors and textures make them ideal for dietary supplements and culinary applications.

Additionally, rising consumer awareness of the benefits of plant-based diets and holistic wellness practices has boosted the demand for leaves-based herbal products. This growing interest is driving market expansion and solidifying the leaves segment's leadership in the herbal medicine industry.

Country/Region-wise Acumens

Will Growing Demand for Natural And Plant-Based Therapies in Europe Mature Herbal Medicine Market?

Europe dominates the herbal medicine market due to several key factors. The region benefits from a rising geriatric population and increasing prevalence of chronic diseases, prompting a growing demand for natural and plant-based therapies as alternatives or complements to conventional medicine. This demographic shift has bolstered the adoption of herbal remedies, driving market expansion.

Increasing awareness of the benefits of herbal remedies and rising consumer preference for sustainable products. The European herbal medicine market is being driven by the growing popularity of herbal teas and supplements, the emergence of boutique brands, and the integration of herbs into functional foods and beverages. Despite regulatory challenges, consumers are seeking natural alternatives for their healthcare needs, contributing to the market's growth.

Europe's integration of traditional herbal medicines into mainstream healthcare practices contributes significantly to market dominance. Many European countries have established regulatory frameworks that support the safe and effective use of herbal products, enhancing consumer confidence and regulatory compliance.

Europe's diverse array of herbal products spans three distinct categories: prescription drugs, over-the-counter (OTC) phytomedicines, and traditional herbal remedies. This variety caters to a broad spectrum of consumer needs and preferences, offering both regulated pharmaceutical-grade treatments and traditional remedies that have gained acceptance through generations of use. This diversity and regulatory framework contribute to Europe's robust and evolving herbal medicine market.

Will Increasing Consumer Awareness about the Benefits of Natural Remedies Enhance Adoption of Herbal Medicine in Asia Pacific?

The Asia Pacific herbal medicine market is experiencing rapid growth, driven by a long history of traditional medicine, increasing consumer awareness of natural remedies, and rising healthcare costs. Traditional practices in countries like India, China, and Japan contribute to the market's growth. The region's diverse range of botanical remedies and large consumer base contribute significantly to the global market.

China is a major exporter of herbal medicines and essential oils, followed by India and Indonesia. The Chinese traditional medicines industry is supported by favorable government policies, heavy research investments, and high consumer adoption. The Chinese Journal of Traditional Chinese Medicine reports that around USS 3.0 billion worth of traditional Chinese medicines are exported annually, and over 500 million practitioners consult, accounting for around 20% of Chinese outpatient visits.

The Asia Pacific herbal medicine market has grown due to a growing interest in traditional medicine practices like Traditional Chinese Medicine (TCM) and Ayurveda. These ancient healing methods emphasize the use of herbs and natural remedies for preventive care and treatment, leading to an increased demand for herbal supplements as consumers seek natural alternatives to synthetic drugs.

Competitive Landscape

The competitive landscape of the herbal medicine market is characterized by a diverse array of players ranging from established pharmaceutical companies to traditional medicine practitioners and smaller herbal product manufacturers. These entities compete based on factors such as product quality, efficacy, safety, pricing, distribution channels, and regulatory compliance. Market dynamics are shaped by increasing consumer demand for natural and alternative therapies, stringent regulatory standards, and ongoing research and development efforts to validate the efficacy of herbal remedies. The landscape is further influenced by partnerships, strategic alliances, and investments in technological advancements aimed at enhancing the formulation, production, and distribution of herbal medicines globally. Some of the prominent players operating in the herbal medicine market include:

Himalaya Wellness

Dabur India Ltd.

Schwabe Group

Tsumura & Co.

Blackmores Ltd.

Bio-Botanica, Inc.

Nature's Bounty Co.

Ricola AG

Young Living Essential Oils

Gaia Herbs

Nutraceutical International Corporation

Arizona Natural Products

Nature's Sunshine Products

Bioforce AG (A.Vogel)

Bach Flower Remedies Ltd.

Pukka Herbs Ltd.

MediHerb (a subsidiary of Integria Healthcare)

Weleda AG

Herbalife Nutrition Ltd.

Boiron

Latest Developments

In June 2023, Traditional Medicinals, a leading North American botanical wellness company, has introduced its Organic Lemon Ginger tea in Canada. This refreshing blend, made from organic herbal ingredients like lemon peel, ginger, hibiscus, and lemongrass, offers a zesty, sweet, and slightly spicy taste, suitable for hot or cold consumption.

In January 2023, Handard, an Indian traditional medicine manufacturer, has expanded its product range to include face washes, shampoos, and oral hygiene products.

In January 2022, Blackmores Ltd., an Australian natural health and dietary supplement company, has partnered with B28 e-commerce platform Udaan to distribute its multivitamin products in India, available at independent pharmacies through Udaan.

Herbal Medicine Market, By Category

• Form:
• Tablets and Capsules
• Powders
• Capsules and Tablets
• Syrups
• Extracts
• Source:
• Leaves
• Root and Barks
• Whole Plants and Fruits
• Distribution Channel:
• Hospital
• Retail Pharmacies
• E-Commerce
• Indication/Therapeutic Use:
• Digestive Health
• Respiratory Health
• Cardiovascular Health
• Joint and Musculoskeletal Health
• Stress Management/Mental Health
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Herbal Medicine Market, By Form

• Tablets and Capsules
• Powders
• Capsules and Tablets
• Syrups
• Extracts

5. Herbal Medicine Market, By Source

• Leaves
• Root and Barks
• Whole Plants and Fruits

6. Herbal Medicine Market, By Distribution Channel

• Hospital
• Retail Pharmacies
• E-Commerce

7. Herbal Medicine Market, By Indication/Therapeutic Use

• Digestive Health
• Immune Support
• Respiratory Health
• Cardiovascular Health
• Joint and Musculoskeletal Health
• Stress Management/Mental Health

8. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

9. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

10. Competitive Landscape

• Key Players
• Market Share Analysis

11. Company Profiles

• Abbott Laboratories
• F. Hoffmann-La Roche Ltd.
• Novartis International AG
• Bayer AG
• Pfizer Inc.
• GlaxoSmithKline plc.
• Sanofi S.A.
• Merck & Co., Inc.
• Eli Lilly and Company
• Johnson & Johnson
• Nestle S.A.
• Herbalife International of America, Inc.
• Amway Corporation
• Nature's Sunshine Products, Inc.
• Dabur India Ltd.
• Himalaya Global Holdings Ltd.

12. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

13. Appendix

• List of Abbreviations
• Sources and References